Phosphofructokinase activity in fibroblasts aneuploid for chromosome 21
- PMID: 2952576
- DOI: 10.1007/BF00283052
Phosphofructokinase activity in fibroblasts aneuploid for chromosome 21
Abstract
Although the gene for the liver type (L) subunit of phosphofructokinase (PFK) is located on human chromosome 21 and PFKL subunits predominate in fibroblasts, an increase in PFK activity has not been reported in trisomy 21 fibroblasts. However, using well-matched pairs of trisomy 21 and diploid fibroblast strains, we observed an almost 1.5-fold increase in mean PFK activity of trisomic cells. In monosomy 21 fibroblasts we found an almost 0.5-fold decrease in mean PFK activity. Thus there appears to be a gene-dosage effect for the PFKL gene, as for other loci on chromosome 21. PFK activity in a cell strain deleted for the distal part of band 21q22.3 was not decreased, suggesting with other data that PFKL is located in the midportion of band 21q22.3.
Similar articles
-
Assignment of the human gene for liver-type 6-phosphofructokinase isozyme (PFKL) to chromosome 21 by using somatic cell hybrids and monoclonal anti-L antibody.Proc Natl Acad Sci U S A. 1981 Jun;78(6):3738-42. doi: 10.1073/pnas.78.6.3738. Proc Natl Acad Sci U S A. 1981. PMID: 6455664 Free PMC article.
-
Overexpression of liver-type phosphofructokinase (PFKL) in transgenic-PFKL mice: implication for gene dosage in trisomy 21.Biochem J. 1994 Apr 15;299 ( Pt 2)(Pt 2):409-15. doi: 10.1042/bj2990409. Biochem J. 1994. PMID: 8172601 Free PMC article.
-
Regional assignment of human liver-type 6-phosphofructokinase to chromosome 21q22.3 by using somatic cell hybrids and a monoclonal anti-L antibody.Hum Genet. 1986 Sep;74(1):34-40. doi: 10.1007/BF00278782. Hum Genet. 1986. PMID: 2944814
-
[Phosphofructokinase (PFK)].Nihon Rinsho. 1995 May;53(5):1241-6. Nihon Rinsho. 1995. PMID: 7602786 Review. Japanese.
-
Gene dosage effects of PFKL in transfected PC12 cells.Prog Clin Biol Res. 1993;384:135-56. Prog Clin Biol Res. 1993. PMID: 8115399 Review. No abstract available.
Cited by
-
Down syndrome is an oxidative phosphorylation disorder.Redox Biol. 2021 May;41:101871. doi: 10.1016/j.redox.2021.101871. Epub 2021 Jan 22. Redox Biol. 2021. PMID: 33540295 Free PMC article.
-
Effects of overexpression of the liver subunit of 6-phosphofructo-1-kinase on the metabolism of a cultured mammalian cell line.Biochem J. 2000 Dec 15;352 Pt 3(Pt 3):921-7. Biochem J. 2000. PMID: 11104704 Free PMC article.
-
Analysis of gene-dosage effects on the expression of CD18 by trisomy 21 lymphoblastoid cell-lines using a statistical model to fit flow cytometry profiles.Hum Genet. 1990 Dec;86(2):181-6. doi: 10.1007/BF00197702. Hum Genet. 1990. PMID: 1979957
-
Connectivity Analyses of Bioenergetic Changes in Schizophrenia: Identification of Novel Treatments.Mol Neurobiol. 2019 Jun;56(6):4492-4517. doi: 10.1007/s12035-018-1390-4. Epub 2018 Oct 18. Mol Neurobiol. 2019. PMID: 30338483 Free PMC article.
-
Meta-analysis of metabolites involved in bioenergetic pathways reveals a pseudohypoxic state in Down syndrome.Mol Med. 2020 Nov 9;26(1):102. doi: 10.1186/s10020-020-00225-8. Mol Med. 2020. PMID: 33167881 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical
Miscellaneous